← All trials
NCT01243112
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2010
- Primary completion
- Sep 1, 2010
- Completion date
- Sep 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 25
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Scott and White HealthcareLead sponsor
- Scott and White HealthcareReponsible party - principal investigator
- Scott and White HealthcareOverall official - principal investigator
- Scott and White HealthcareStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.